Nanomedicine and Ophthalmology: looking forward
; Araújo, M.A.
Ferreira, J. F.
; Leal, I. L.
; Neves, C. M. N.
Acta Ophthalmologica Vol. 93, Nº S255, pp. n.a - n.a, October, 2015.
ISSN (print): 1755-3768
Journal Impact Factor: 2,844 (in 2014)
Digital Object Identifier: 10.1111/j.1755-3768.2015.0669
Nanomedicine has been receiving greater attention in recent years due to the ability to use materials and devices at the size of intracellular structures and molecules, involving systems in the order of <100 nm. In particular, nanosized materials can provide substantial advantages when compared to current therapeutics that are used in the treatment of ocular diseases. Nanotechnology-based approaches are being explored in order to enhance drug permeation, to control mechanisms of drug release and to improve the action of nanocarriers with specific targeting moieties. From biopharmaceuticals to continuous intraocular pressure biosensors and tissue regeneration, nanotechnology provides an impressive range of possibilities to explore and improve patient care.